| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 1,663,992 | 922,066 | 637,235 | | Cost of Revenue | 1,234,790 | 957,598 | 697,968 | | | Gross Profit | 429,202 | (35,532) | (60,733) | | | Operating Expenses | | Research Development | 40,496 | 41,343 | 70,127 | | Selling General and Administrative | 445,079 | 329,435 | 831,115 | | Non Recurring | 4,776,624 |
-
|
-
| | Others | 203,752 | 106,780 | 105,749 | | | | Total Operating Expenses | 5,465,951 |
-
|
-
| | | | Operating Income or Loss | (5,036,749) | (513,090) | (1,067,724) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (129,230) | 20,601 | 33,399 | | Earnings Before Interest And Taxes | (5,165,979) | (492,489) | (1,038,770) | | Interest Expense | 144,833 | 70,328 | 64,032 | | Income Before Tax | (5,310,812) | (562,817) | (1,102,802) | | Income Tax Expense | 2,476 | 2,435 | 2,065 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,313,288) | (565,252) | (1,104,867) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (5,313,288) | (565,252) | (1,104,867) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,313,288) | ($565,252) | ($1,104,867) |
|
1.29% Nasdaq 0.00%
Income Statement
